DuPont(US:DD) Prnewswire·2025-05-22 13:00Core Insights - DuPont has launched the DuPont™ AmberChrom™ TQ1 chromatography resin aimed at enhancing the purification of oligonucleotides and peptides for biopharma applications [1][2]. Product Features - The new resin offers increased loading capacity, higher throughput, and lower pressure requirements compared to competing products, making it suitable for high-resolution separations and polishing [2]. - It provides high purity fractions in biomolecule purifications and effectively separates closely-related impurities from target molecules [2]. - The resin is designed for both benchtop and large-scale commercial purifications, ensuring high yield and purity for peptides and oligonucleotides [2]. Market Positioning - The introduction of the resin is part of DuPont's strategy to expand its bioprocessing portfolio, reflecting a commitment to being a comprehensive provider for the purification of oligonucleotides and peptides [4]. - DuPont's technical teams are actively collaborating with customers to create efficient bioprocessing solutions throughout the drug development process [4]. Validation and Support - DuPont has published internal application studies using real-world drug feeds to validate the performance of the new resin, aiding its integration into various drug development phases [3]. - An educational webinar is scheduled for June 19, 2025, to discuss the capabilities of the new resin and its impact on purification efficacy [6]. Industry Leadership - DuPont is recognized as a global market leader in adsorbents and ion exchange resins, with over 80 years of experience in bioprocessing solutions [7].